New-look interventional device for PAH wins ‘Shark Tank’ event at TCT 2023

HeartPoint Global, a Florida-based healthcare technology company focused on improving patient access to high-quality technology, won the Shark Take Innovation Competition at TCT 2023 with its Intellistent multi-lumen stent system. The device, already patented in more than 20 countries, is designed to help cardiologists treat pulmonary arterial hypertension (PAH) in congenital heart disease patients by allowing for the adjustment of blood flow into the patient’s heart-lung system.

According to HeartPoint Global, the minimally invasive device was designed to deliver benefits comparable to what is typically seen with surgical treatment. It may also serve as a bridge to surgery for some cardiac patients.

“We are deeply honored to be bestowed with this prestigious award,” Seth Bogner, HeartPoint Global’s chairman and CEO, said in a prepared statement. “TCT stands as a pinnacle platform for highlighting innovation in cardiovascular medicine. Having our technology acknowledged by such a distinguished panel of judges is truly humbling. We are eager to forge ahead with HeartPoint Global’s in-human trials and anticipate its substantial clinical impact in the future.”